Complexes {[(PTA)
2
CpRu-μ-CN-1
κC
:2
κ
2
N
-RuCp(PTA)
2
-ZnCl
3
]}·2DMSO (
13
) {[ZnCl
2
(H
2
O)]-(PTA-1κ
P
:2κ
2
N
)(PTA)CpRu-μ-CN-1κ
C
:2κ
2
N
-RuCp(PTA)(PTA-1κ
P
:2κ
2
N
)-[ZnCl
2
(H
2
O)]}Cl (
14
), [RuCp(HdmoPTA)(PPh
3
)(PTA)](CF
3
SO
3
)
2
(
20
), [RuCp(HdmoPTA)(HPTA)(PPh
3
)](CF
3
SO
3
)
3
(
21
), and [RuCp(dmoPTA)(PPh
3
)(PTA)](CF
3
SO
3
) (
22
) were obtained
and characterized, and their crystal structure together with that
of the previously published complex
18
is reported. The
behavior of the 1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane (PTA)
and 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (dmoPTA)
ligands against protonation and κ
N
-coordination
is discussed, on the basis of
15
N nuclear magnetic resonance
data collected on 22 different compounds, including PTA (
1
), HdmoPTA (
7
H), and some common derivatives as free
ligands (
2–6
and
8
), along with mono-
and polymetallic complexes containing PTA and/or HdmoPTA (
9–22
).
15
N detection via
1
H–
15
N heteronuclear multiple bond correlation allowed the construction
of a small library of
15
N chemical shifts that shed light
on important features regarding κ
N
-coordination
in PTA and its derivatives.